PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
5.63
+0.22 (4.07%)
At close: Jan 22, 2026, 4:00 PM EST
5.63
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:50 PM EST
PepGen Market Cap
PepGen has a market cap or net worth of $387.05 million as of January 22, 2026. Its market cap has increased by 210.03% in one year.
Market Cap
387.05M
Enterprise Value
240.83M
1-Year Change
210.03%
Ranking
Category
Stock Price
$5.63
Market Cap Chart
Since May 6, 2022, PepGen's market cap has increased from $288.65M to $387.05M, an increase of 34.09%. That is a compound annual growth rate of 8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 371.93M | -16.90% |
| Dec 31, 2025 | 447.55M | 262.28% |
| Dec 31, 2024 | 123.54M | -23.71% |
| Dec 29, 2023 | 161.93M | -48.75% |
| Dec 30, 2022 | 315.96M | 9.46% |
| May 6, 2022 | 288.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 407.46M |
| vTv Therapeutics | 405.09M |
| Benitec Biopharma | 402.96M |
| Rocket Pharmaceuticals | 401.50M |
| DiaMedica Therapeutics | 400.77M |
| Entrada Therapeutics | 399.14M |
| Lineage Cell Therapeutics | 396.21M |
| Autolus Therapeutics | 381.92M |